ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock Income Statement
NASDAQ:ARTV - Nasdaq - US04317A1079 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 251.00K | 33.49M | 4.93M | 2.00M | |||
| Operating Expenses | 67.53M | 64.16M | 64.76M | 55.27M | |||
| Research and Development | 50.33M | 50.25M | 43.98M | 42.41M | |||
| Selling, General, and Administrative Expenses | 17.20M | 13.91M | 20.78M | 12.86M | |||
| Operating Income | -67.28M | -30.67M | -59.83M | -53.27M | |||
| Interest Income/Expense | 5.35M | 2.54M | 1.29M | 0.00 | |||
| Other Income/Expense | -3.44M | -512.00K | -200.00K | -18.55M | |||
| Income Before Taxes | -65.37M | -28.65M | -58.73M | -71.83M | |||
| Income Tax | 0.00 | 72.00K | 53.00K | N/A | |||
| Net Income | -65.37M | -28.72M | -58.79M | -71.83M | |||
| EBITDA | -64.85M | -28.41M | -58.67M | -53.02M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -5.81 | -1.23 | -2.53 | -3.09 | |||
| Statistics | |||||||
| Profit Margin | -26045.02% | -85.75% | -1192.21% | -3587.66% | |||
| Operating Profit Margin | -26805.58% | -91.58% | -1213.32% | -2660.94% | |||
All data in USD